39
2
2
176
Cat. No. | Product Name | Form | Specificity Of Inhibition |
---|---|---|---|
C0068 |
Mouse CD8+ Cell Isolation Kit (positive selection)
小鼠 CD8+ 细胞分选试剂盒 (阳选) |
||
C0063 |
Mouse CD8+ T Cell Isolation Kit (negative selection)
小鼠 CD8+ T细胞分选试剂盒 (阴选) |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T78259 |
Anti-Mouse CD8 beta Antibody (53-5.8)
|
||
Anti-Mouse CD8 beta Antibody是一种源自大鼠的IgG1类免疫抑制性抗体,专门针对小鼠的CD8 beta分子。 | |||
T10722 |
CD80-IN-3
|
Bombesin Receptor | GPCR/G Protein |
CD80-IN-3 是一种CD80抑制剂,抑制 CD80/CD28 互作的EC50=630 nM,Kd=125 nM。 | |||
T78260 |
Anti-Mouse CD8a Antibody (53-6.7)
|
||
Anti-MouseCD8aAntibody为针对小鼠CD8a的IgG2a亚型单克隆抗体,其宿主为大鼠。 | |||
TQ0291 |
Firategrast
SB 683699 |
Integrin | Cytoskeletal Signaling |
Firategrast (SB 683699) 是一种具有口服活性和特异性的α4β1/α4β7整合素拮抗剂。Firategrast 减少淋巴细胞进入中枢神经系统 (CNS) 的运输,降低多发性硬化症 (MS) 的活性。Firategrast 用于复发缓解性多发性硬化症。Firategrast 治疗与中位脑脊液与 CD4,CD8和CD19淋巴细胞计数的适度降低有关。 | |||
T7739 |
L-Leucyl-L-Leucine methyl ester hydrochloride
Leu-Leu-ome hydrochloride |
Others; Endogenous Metabolite | Metabolism; Others |
L-Leucyl-L-Leucine methyl ester hydrochloride (Leu-Leu-ome hydrochloride) 是一种人单核细胞或多形核白细胞产生的 L-亮氨酸甲酯的二肽缩合产物,能够选择性消除具有细胞毒性潜能的淋巴细胞,也能够诱导溶酶体途径应激。 | |||
T82670 |
Crefmirlimab
89Zr-Df-IAB22M2C |
||
Crefmirlimab(89Zr-Df-IAB22M2C)为针对CD8抗原的人源化CD8探针,适用于多种癌症诊断。 | |||
T80962 |
TPNQRQNVC
LRH-1 peptide |
||
TPNQRQNVC为HLA-B0702的九肽抗原决定簇,能激活CD8+ T细胞的免疫响应。 | |||
T62927 | HPK1-IN-22 | ||
HPK1-IN-22 (compound ZYF0033) 是一种造血祖细胞激酶 1 (HPK1) 抑制剂,基于 MBP 蛋白的磷酸化抑制作用的 IC50小于 10 nM。HPK1-IN-22 能够减少 SLP76 (丝氨酸 376) 的磷酸化,促进抗癌免疫反应。HPK1-IN-22 可以抑制 4T-1 同基因小鼠模型中的肿瘤生长,增加 DC、NK 细胞和 CD107a+CD8+T 细胞的肿瘤内浸润,但会减少 T 细胞、PD-1+CD8+T 细胞、TIM-3+CD8+T 细胞和 LAG3+CD8+T 细胞的浸润。 | |||
T76530 |
HBV Seq2 aa:208-216
|
||
HBVSeq2 aa:208-216,作为HBsAg衍生的CD8表位肽,是乙型肝炎病毒大包膜蛋白一部分,目前正被研究。 | |||
T64277 |
ODN 1585
|
||
ODN 1585 是一种有效的 IFN 和 TNFα 产生诱导剂,也是一种 NK (natural killer) 的有效刺激剂,可用做疫苗佐剂。ODN 1585 能够增强 CD8+ T 细胞的功能,包括 CD8+ T 细胞介导的 IFN-γ 的产生。ODN 1585 可以诱导小鼠已建立的黑色素瘤消退,对小鼠的疟疾也表现出完全的保护作用。ODN 1585 能够用于研究急性骨髓性白血病 (AML) 和疟疾。 | |||
T78275 |
Ivuxolimab
|
||
Ivuxolimab为针对OX40(亦称CD134;TNFRSF4)的激动型单克隆抗体。该抗体针对活化CD4+及CD8+T细胞表面的共刺激受体,具备抗肿瘤能力和潜在免疫刺激作用。 | |||
T80907 |
TYVPANASL
|
||
TYVPANASL为由HER2/neu的9个氨基酸组成的MHC I结合CD8 T细胞表位,可用于制备J-LEAPS疫苗。 | |||
T81733 |
Myelin Oligodendrocyte Glycoprotein (40-54), Rat, Mouse
MOG (40-54) |
||
Myelin Oligodendrocyte Glycoprotein (40-54), Rat, Mouse (MOG (40-54)) 是一种与 H-2Db 关联的CD8+T细胞自身抗原表位,来源于髓鞘少突神经胶质细胞糖蛋白 (MOG)。 | |||
T77171 |
Efineptakin alfa
|
||
Efineptakin alfa (NT-17) 是一种长效重组人 IL-7。 Efineptakin alfa 支持人和小鼠体内 CD4+和 CD8+细胞的增殖和存活。 Efineptakin alfa 可用于胶质母细胞瘤的研究。 | |||
T82743 |
CFP10 (71–85)
|
||
CFP10 (71–85) 是具生物活性的肽类,能激活表达不同MHC II类与I类分子的人类CD4+和CD8+ T细胞,诱导IFN-γ产生及CTL活性。(CFP10 71–85). | |||
T78332 |
Eftilagimod alfa
IMP321,LAG-3Ig |
||
Eftilagimod alfa为重组LAG-3Ig融合蛋白,具有MHC II 类分子结合能力。该药物通过介导抗原提呈细胞(APC)的激活进而激活CD8 T细胞,可用于研究转移性黑色素瘤及转移性乳腺癌。 | |||
T80906 |
TYVPANASL TFA
|
||
TYVPANASL TFA,一种由HER2/neu的9个氨基酸组成,可结合MHC I并与CD8 T细胞表位相关的化合物。该化合物可用于制备J-LEAPS疫苗。 | |||
T72680 |
PD-1/PD-L1-IN-27
|
PD-1/PD-L1 | Apoptosis; Cell Cycle/Checkpoint; Immunology/Inflammation |
PD-1/PD-L1-IN-27是一种针对PD-1/PD-L1的有效抑制剂,具有134 nM的IC50值。该化合物表现出具有低T细胞毒性的抗肿瘤活性,并能够激活CD8+T细胞以及减少T细胞耗竭。 | |||
T39292 |
NS2 (114-121), Influenza
NS2 (114-121), Influenza |
||
NS2 (114-121), Influenza, is a fragment derived from the nonstructural protein 2 (NS2) of the influenza virus. This compound serves as an epitope for influenza research and can be utilized to study the CD8+ cytotoxic T lymphocyte (CTL) in antiviral immune responses. | |||
T72670 |
PD-1/PD-L1-IN-13
|
||
PD-1/PD-L1-IN-13 是一种有效的免疫检查点 PD-1/PD-L1抑制剂,对 PD-1/PD- L1 相互作用的 IC50值为 10.2 nM。PD-1/PD-L1-IN-13 在 Hepa1-6 同系小鼠模型中促进 CD8+T 细胞活化并延缓肿瘤生长。 | |||
T82508 |
Eciskafusp alfa
|
PD-1/PD-L1 | Apoptosis; Cell Cycle/Checkpoint; Immunology/Inflammation |
Eciskafusp alfa是一种针对程序性细胞死亡1(PDCD1,亦称PD-1)的顺式靶向IL2v免疫细胞因子。它优先选择抗原特异性干细胞样PD-1+ TCF-1+ CD8+ T细胞,并促使这些细胞分化成更高效的效应器细胞。Eciskafusp alfa主要用于癌症与慢性感染的研究领域。 | |||
T83852 |
EGFRvIII Peptide TFA
PEGFRvIII (9-mer),Epidermal Growth Factor Receptor Variant III Peptide |
||
EGFRvIII peptide是一种合成肽,对应于特异性肿瘤、具有持续激活性的EGFR变体EGFRvIII的融合接头,该变体缺少野生型EGFR的第6至273个氨基酸。在25 µg/ml的浓度下,它能与MHC I类亚型HLA-A*0201阳性的T2细胞结合。在用于分离的人外周血单个核细胞(PBMCs)衍生的树突状细胞中,EGFRvIII peptide可诱导抗原呈递,进而刺激CD8+细胞毒性T淋巴细胞的激活和IFN-γ产生。与toll样受体5(TLR5)激动剂鞭毛蛋白B共同免疫EGFRvIII peptide(15 µg/动物),在正交GL261胶质母细胞瘤小鼠异种移植模型中,增加了CD8+ T细胞数量,减少了调节性T细胞(Tregs)数量,减少了肿瘤体积,并提高了生存率。 | |||
TP1752 |
GP(33-41)
|
||
GP(33-41), a 9-aa-long peptide, is the optimal sequence of the GP1 epitope of lymphocytic choriomeningitis virus, and can upregulate H-2Db molecules at the RMA-S (Db Kb) cell surface with a SC50 of 344 nM. GP33-41 Epitopeis a strong agonist of CD8 T cells | |||
T78836 |
IHMT-PI3K-455
|
PI3K | PI3K/Akt/mTOR signaling |
IHMT-PI3K-455(Compound 15u)为一种高效、选择性且具口服活性的PI3Kγ/δ双重抑制剂,其针对PI3Kγ与PI3Kδ的IC50值分别为7.1 nM和0.57 nM。该化合物能够抑制AKT磷酸化,并通过促进CD8+杀伤性T细胞的招募与激活,抑制肿瘤生长,适用于肿瘤学研究领域。 | |||
T64022 | Antitumor agent-37 | ||
Antitumor agent-37 表现出有效的抗增殖和抗转移效果。Antitumor agent-37 能够诱导严重的 DNA 损伤,进而导致 γ-H2AX 和 p53 的高表达。Antitumor agent-37 可利用线粒体凋亡通路 Bcl-2/Bax/caspase3,诱导肿瘤细胞凋亡 (apoptosis)。Antitumor agent-37 可以抑制 PD-L1 的表达,提高肿瘤组织中 CD3+ 和 CD8+ T 浸润细胞,明显改善免疫反应。 | |||
T74393 | Antitumor agent-36 | ||
Antitumor agent-36 具有有效的抗增殖和抗转移活性,能诱导严重的 DNA 损伤,并通过增加 γ-H2AX 和 p53 的表达促进肿瘤细胞通过 Bcl-2/Bax/caspase3 线粒体凋亡通路的 (apoptosis)。此外,Antitumor agent-36 还能通过抑制 PD-L1 的表达显著增加肿瘤组织中 CD3+ 和 CD8+ T 浸润细胞,从而改善免疫反应。 | |||
T71890 |
F5446
|
||
F5446 is a SUV39H1 inhibitor. F5446 has an EC50 of 0.496 μmol/L for SUV39H1 enzymatic activity. H3K9me3 was enriched in the promoters of GZMB, PRF1, FASLG, and IFNG in quiescent T cells. F5446 inhibited H3K9me3, thereby upregulating expression of these effectors in tumor-infiltrating CTLs and suppressing colon carcinoma growth in a CD8+ CTL-dependent manner in vivo. Our data indicate that SUV39H1 represses CTL effector gene expression and, in doing so, confers colon cancer immune escape. | |||
T40132 |
Insulin β Chain Peptide (15-23)
|
||
Insulin β Chain Peptide (15-23), also referred to as INS, is an insulin-derived peptide that is specifically recognized by islet-associated T cells. The tetramer of Insulin β Chain Peptide (15-23) effectively stained the INS-reactive CTL clone G9C8; however, neither this tetramer nor the negative control tetramer (TUM) exhibited staining on the splenic CD8+ T cells obtained from NOD or 8.3-TCRαβ transgenic NOD mice. | |||
T36116 |
Concanamycin B
|
||
Concanamycin B is a macrolide antibiotic that selectively inhibits vacuolar type H+-ATPases, also known as V-ATPases (IC50 = 5 nM). In this way, it blocks the acidification of vacuolar organelles as well as early to late endosomal transport. Concanamycin B interferes with bone resorption and maturation of CD8 T lymphocytes. It also prevents processing of major histocompatibility complex (MHC) class II precursors in human B cells, inhibiting the expression of MHC class II molecules on the cell su... | |||
T36034 | CAY10774 | ||
CAY10774 is an inhibitor of the protein-protein interaction between programmed cell death 1 (PD-1) and its ligand PD-L1 (IC50= 15 nM in a homologous time-resolved fret (HTRF) assay).1It increases the activation of Jurkat cells expressing PD-1 in co-culture with artificial antigen-presenting cells (aAPCs) expressing PD-L1 (EC50= 6.6 μM in a reporter assay). CAY10774 increases surface expression of PD-1 on primary human CD4+and CD8+T cells co-cultured with aAPCs. 1.Konieczny, M., Musielak, B., Koc... | |||
T81968 |
KY-1044
SAR 445256,Alomfilimab |
||
KY-1044 (Alomfilimab; SAR 445256) 是一种全人IgG1抗体,针对诱导型共刺激受体(ICOS)。该化合物借助FcgRIIIa作用,通过抗体依赖性细胞毒性(ADCC)清除高表达ICOS的细胞,并在低表达ICOS的CD8+TEff细胞上通过FcgR依赖的聚集发挥共刺激作用。通过操纵T细胞亚型上ICOS的异质性表达,KY-1044旨在优化肿瘤微环境,并恢复对肿瘤的免疫应答。 | |||
T68182 |
3-Hydroxykynurenamine
|
||
3-Hydroxykynurenamine, also known as 3-Hydroxy-L-kynurenamine or 3-HKA, is a biogenic amine produced via an alternative pathway of tryptophan metabolism. In vitro, 3-HKA has an anti-inflammatory profile by inhibiting the IFN-γ mediated STAT1/NF-κΒ pathway in both mouse and human dendritic cells (DCs) with a consequent decrease in the release of pro-inflammatory chemokines and cytokines, most notably TNF, IL-6, and IL12p70. 3-HKA has protective effects in an experimental mouse model of psoriasis ... | |||
TP1727 |
Gp100 (25-33), human
|
||
Gp100 (25-33), human is the amino acids 25-33 fragment of the human melanoma antigen. It is a 9-amino acid (AA) epitope restricted by H-2Db and recognized by the T cells.This is amino acids 25 to 33 fragment of human melanoma antigen gp100. This H-2Db res | |||
T83779 |
EP4 Antagonist 14
Prostaglandin E2 Receptor 4 Antagonist 14,PGE2 Receptor 4 Antagonist 14 |
||
EP4 antagonist 14是一种前列腺素E2(PGE2)受体亚型EP4的拮抗剂,其在使用表达人源受体的HEK293细胞的报告基因测定中的IC50值为1.1 nM。它还能抑制PGE2诱导的同种细胞中的β-阿雷斯汀招募(IC50 = 0.9 nM)。EP4 antagonist 14(10 µM)能减少RAW 264.7巨噬细胞中PGE2诱导的mRNA表达,这些mRNA编码Il-4、巨噬细胞甘露糖受体1(Mrc1)、几丁质酶样蛋白3(Chil3)、趋化因子(C-X-C)基序配体1(Cxcl1)、表达在髓样细胞上的触发受体2(Trem2)和精氨酸酶-1(Arg1)。在体内,EP4 antagonist 14(每天30 mg/kg),结合抗PD-1抗体,能够在CT26小鼠结肠癌模型中抑制肿瘤生长并增加CD8+ T细胞对肿瘤的浸润。 | |||
T70928 |
CB-1158-analog
|
||
CB-1158-analog, also known as Numidargistat-analog and INCB01158-analog, is a potent and orally active arginase inhibitor with IC50=89 nM) . CB-1158 blocked myeloid cell-mediated suppression of T cell proliferation in vitro and reduced tumor growth in multiple mouse models of cancer, as a single agent and in combination with checkpoint blockade, adoptive T cell therapy, adoptive NK cell therapy, and the chemotherapy agent gemcitabine. CB-1158 increased tumor-infiltrating CD8+ T cells and NK cell... | |||
T35573 |
Adenosine 5’-methylenediphosphate (hydrate)
|
||
Adenosine 5’-methylenediphosphate is an inhibitor of ecto-5’-nucleotidase, also known as CD73, with a Kivalue of 37 nM.1It inhibits cAMP accumulation induced by adenosine 5’-monophosphate , adenosine 5’-diphosphate , or adenosine 5’-triphosphate but not adenosine in VA-13 human fibroblasts when used at a concentration of 100 μM. Adenosine 5’-methylenediphosphate reduces proliferation of U138MG glioma cells, as well as inhibits the invasion and migration of MHCC97H hepatocellular carcinoma (HCC) ... | |||
T37295 |
Ganglioside GM1 Asialo Mixture
|
||
Ganglioside GM1 asialo is a component of cellular lipid rafts and can be formed by the cleavage of the sialic acid residue from ganglioside GM1 by neuraminidase. Ganglioside GM1 asialo is a glycolipid receptor for P. aeruginosa flagellin and stimulates defensive responses in host cells, including extracellular ATP release, calcium mobilization, and ERK1/2 phosphorylation when stimulated by flagellin and an anti-ganglioside GM1 asialo antibody. The percentage of ganglioside GM1 asialo-positive na... | |||
T82071 |
Influenza NP (311-325)
|
||
Influenza NP (311-325) 是具有生物活性的肽段,对应于流感病毒核蛋白(NP)的311至325氨基酸。作为MHC II类限制性表位,它用于研究宿主在感染期间的免疫响应。该肽能在细胞内细胞因子检测中诱导强烈的γ干扰素(IFN-γ)产生,但不激活小鼠CD8 T细胞。谷氨酰胺(Q)或谷氨酸(E)位于N端时,焦谷氨酰(pGlu)肽可自发形成。Q或E向pGlu的自然转化及其疏水性γ-内酰胺环在肽的胃肠道蛋白酶稳定性中可能起作用。焦谷氨酰肽作为常见肽的一部分,在HPLC分析中评估肽的纯度。 | |||
T83910 |
S1PL-IN-31
Sphingosine-1-Phosphate Lyase Inhibitor 31,S1PL Inhibitor 31,S1P Lyase Inhibitor 31 |
||
S1PL-IN-31是一种鞘氨醇-1-磷酸(S1P)裂解酶的抑制剂(IC50 = 210 nM),同时也是Smoothened(Smo)受体的对抗剂(IC50 = 440 nM)。在体内,S1PL-IN-31 (每天2 mg/kg)能够防止实验性自身免疫性脑炎(EAE)模型大鼠中,由髓鞘少突胶质细胞糖蛋白(MOG)肽段MOG29-152诱发的颈部及胸部淋巴细胞渗透和神经肌肉虚弱。该化合物降低了大鼠的淋巴细胞总数及CD4+ T细胞、CD8+ T细胞和B细胞的水平。S1PL-IN-31 (每天3及10 mg/kg剂量)在雄性和雌性大鼠心脏和淋巴结中增加了S1P水平,并且在雌性大鼠中降低了心率。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TWA2417 |
Sodium taurocholate
牛黄胆酸钠(牛胆酸钠,牛胆酸钠盐,牛磺膽酸鈉,牛磺胆酸钠,牛磺胆酸钠盐,牛胆酸钠水合物,水合牛磺胆酸钠,牛胆酸钠(混合物),牛黄胆酸钠(水合),牛磺胆酸钠(标准品)),Taurocholate Sodium |
Others | Others |
Sodium taurocholate (Taurocholate Sodium) hydrate 具有显著的生物学效应,例如通过上调 VEGF-A 的表达抑制肝动脉结扎所致的胆道损伤。对免疫系统具有一定的调节作用。 | |||
TQ0194 |
trans-Vaccenic acid
TVA,(11E)-octadec-11-enoic acid,11E)-octadec-11-enoic acid |
Endogenous Metabolite | Metabolism |
Trans-Vaccenic acid(TVA)是一种天然存在的反式脂肪酸,存在于反刍动物的脂肪和乳制品中,可通过 GPCR-CREB 通路调控 CD8+ T 细胞增殖,具有抗肿瘤活性。Trans-Vaccenic acid 可在瘤胃中合成饱和脂肪酸,在组织水平合成共轭亚油酸。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-05364 |
CD8 alpha Protein, Human, Recombinant (hFc)
Leu-2,p32 186910,p32,CD8 α,CD... |
Human | HEK293 Cells |
CD8 alpha Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 44.3 kDa and the accession number is P01732-1. | |||
TMPY-05350 |
CD8 alpha Protein, Cynomolgus, Recombinant (hFc)
CD8 α,CD8a molecule |
Cynomolgus | HEK293 Cells |
CD8 alpha Protein, Cynomolgus, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 44.4 kDa and the accession number is XP_005575419.1. | |||
TMPY-05134 |
CD8 alpha Protein, Mouse, Recombinant (His), Biotinylated
Lyt-2,Ly-35,Ly-B,CD8a molecule,Ly-2,BB1543... |
Mouse | HEK293 Cells |
CD8 alpha Protein, Mouse, Recombinant (His), Biotinylated is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 20.3 kDa and the accession number is P01731. | |||
TMPY-04925 |
CD8 beta Protein, Human, Recombinant, Biotinylated
LY3,LYT3,CD8b molecule,P37,LEU2,CD |
Human | HEK293 Cells |
CD8 beta Protein, Human, Recombinant, Biotinylated is expressed in HEK293 mammalian cells. The predicted molecular weight is 17.6 kDa and the accession number is P10966-1. | |||
TMPY-06274 |
CD8 alpha Protein, Human, Recombinant (His)
CD8 alpha,Leu-2,p32 186910,CD... |
Human | CHO Cells |
CD8 alpha Protein, Human, Recombinant (His) is expressed in CHO mammalian cells with His tag. The predicted molecular weight is 19 kDa and the accession number is P01732-1. | |||
TMPY-06275 |
CD8 alpha Protein, Human, Recombinant (His), Biotinylated
MAL,CD8,CD8a molecule,Le... |
Human | CHO Cells |
CD8 alpha Protein, Human, Recombinant (His), Biotinylated is expressed in CHO mammalian cells with His tag. The predicted molecular weight is 19 kDa and the accession number is P01732-1. | |||
TMPY-06256 |
CD8 beta Protein, Cynomolgus, Recombinant (hFc)
CD8 β,CD8b molecule |
Cynomolgus | HEK293 Cells |
CD8 beta Protein, Cynomolgus, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 43.88 kDa and the accession number is XP_005575417.1. | |||
TMPY-02165 |
CD8 alpha Protein, Ferret, Recombinant (His)
CD8a molecule,CD8 α |
Ferret | HEK293 Cells |
CD8 alpha Protein, Ferret, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 19.5 kDa and the accession number is I6LI23. | |||
TMPY-06933 |
CD8 alpha Protein, Human, Recombinant (His & Avi), Biotinylated
p32 186910,MAL,CD8,Leu2,CD |
Human | HEK293 Cells |
CD8 alpha Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with His and Avi tag. The predicted molecular weight is 20.87 kDa and the accession number is NP_001759.3. | |||
TMPJ-00092 |
CD8 beta Protein, Human, Recombinant (His)
T-Cell Surface Glycoprotein CD8 Beta Chain... |
Human | HEK293 Cells |
T-Cell Surface Glycoprotein CD8β Chain (CD8 Antigen) is a cell surface glycoprotein found on most cytotoxic T lymphocytes that mediates efficient cell-cell interactions within the immune system. CD8 Antigen, acting as a coreceptor, and the T-cell receptor on the T lymphocyte recognize antigens displayed by an antigen presenting cell (APC) in the context of class I MHC molecules. The functional coreceptor is either a homodimer composed of two alpha chains, or a heterodimer composed of one alpha a... | |||
TMPY-03913 |
CD8 alpha Protein, Rat, Recombinant (hFc)
CD8 α,CD8a molecule |
Rat | HEK293 Cells |
CD8 alpha Protein, Rat, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 45 kDa and the accession number is P07725. | |||
TMPK-00123 |
CD8 alpha Protein, Human, Recombinant (aa 22-182, His & Avi), Biotinylated
Leu2,CD8 α/CD8A,MAL,Lyt-... |
Human | HEK293 Cells |
CD8 alpha enhances the responses of antigen-specific CTL activated through TCR through binding MHC class I, favoring lipid raft partitioning of TCR, and inducing intracellular signaling. CD8 alpha is also found on dendritic cells and rat macrophages, but whether CD8 alpha enhances responses of a partner receptor, like TCR, to activate these cells is not known. | |||
TMPY-02925 |
CD8 beta Protein, Human, Recombinant
LEU2,P37,CD8b molecule,LYT3,CD |
Human | HEK293 Cells |
CD8 beta Protein, Human, Recombinant is expressed in HEK293 mammalian cells. The predicted molecular weight is 17.6 kDa and the accession number is P10966-1. | |||
TMPY-02703 |
CD8 beta Protein, Human, Recombinant (hFc)
LYT3,CD8 β,CD8b molecule... |
Human | HEK293 Cells |
CD8 beta Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 44 kDa and the accession number is P10966-1. | |||
TMPY-05046 |
CD8 alpha Protein, Mouse, Recombinant (hFc)
BB154331,Ly-B,Ly-2,CD8 α,Lyt-2,Ly-35,C... |
Mouse | HEK293 Cells |
CD8 alpha Protein, Mouse, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 45.6 kDa and the accession number is P01731. | |||
TMPY-01314 |
CD8 alpha Protein, Mouse, Recombinant (His)
Ly-35,CD8a molecule,BB154331,Ly-2,Ly-B, |
Mouse | HEK293 Cells |
CD8 alpha Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 20.3 kDa and the accession number is P01731. | |||
TMPY-04782 |
LILRA1/LIR-6/CD85i Protein, Human, Recombinant (His)
LIR6,leukocyte immunoglobulin like receptor A1,LIR-6,CD<... |
Human | HEK293 Cells |
LILRA1/LIR-6/CD85i Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 50 kDa and the accession number is O75019-1. | |||
TMPY-06076 |
LILRA2/CD85h/ILT1 Protein, Human, Recombinant (hFc)
LIR7,LIR-7,ILT1,CD85H,leukocyte immunoglob... |
Human | HEK293 Cells |
LILRA2/CD85h/ILT1 Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 73.7 kDa and the accession number is Q8N149-1. | |||
TMPY-05161 |
LILRA4/CD85g Protein, Human, Recombinant (His)
leukocyte immunoglobulin like receptor A4,ILT7,CD |
Human | HEK293 Cells |
LILRA4/CD85g Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 48.1 kDa and the accession number is P59901.2. | |||
TMPY-03890 |
CD81 Protein, Human, Recombinant
S5.7,CVID6,TSPAN28,TAPA1,CD81 mol... |
Human | HEK293 Cells |
CD81 Protein, Human, Recombinant is expressed in HEK293 mammalian cells. The predicted molecular weight is 9.9 kDa and the accession number is A0A024RCB7. | |||
TMPY-05669 |
CD8A & CD8B Heterodimer Protein, Human, Recombinant (Flag & His)
|
Human | HEK293 Cells |
CD8A & CD8B Heterodimer Protein, Human, Recombinant (Flag & His) is expressed in HEK293 mammalian cells with Flag and His tag. The predicted molecular weight is 44.1 kDa and the accession number is NP_001759.3&NP_004922.1. | |||
TMPY-00716 |
CD89 Protein, Human, Recombinant (His)
Fc fragment of IgA receptor,CD89,XXbac-BPG... |
Human | HEK293 Cells |
CD89 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 25 kDa and the accession number is P24071-1. | |||
TMPY-05494 |
LILRB3/CD85a Protein, Human, Recombinant (hFc)
LILRA6,CD85A,ILT-5,LIR-3,leukocyte immunog... |
Human | HEK293 Cells |
LILRB3/CD85a Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 72.9 kDa and the accession number is AAI04994.1. | |||
TMPY-03696 |
LILRA3/CD85e Protein, Human, Recombinant (His)
HM43,leukocyte immunoglobulin like receptor A3,LIR-4,LIR4, |
Human | HEK293 Cells |
LILRA3/CD85e Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 58.4 kDa and the accession number is AAH28208.1. | |||
TMPY-03995 |
LILRB1/CD85j/ILT2 Protein, Human, Recombinant (His)
ILT-2,leukocyte immunoglobulin like receptor B1,CD<... |
Human | HEK293 Cells |
LILRB1/CD85j/ILT2 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 48.6 kDa and the accession number is D9IDM8. | |||
TMPY-06077 |
LILRA1/LIR-6/CD85i Protein, Human, Recombinant (hFc)
LIR-6,leukocyte immunoglobulin like receptor A1,LIR6,CD<... |
Human | HEK293 Cells |
LILRA1/LIR-6/CD85i Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 75.3 kDa and the accession number is O75019-1. | |||
TMPY-01829 |
CD83 Protein, Human, Recombinant (His)
BL11,HB15,CD83 molecule |
Human | HEK293 Cells |
CD83 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 15.5 kDa and the accession number is Q01151-1. | |||
TMPY-04826 |
LILRB5/CD85c Protein, Human, Recombinant (His)
leukocyte immunoglobulin like receptor B5,LIR8,LIR-... |
Human | HEK293 Cells |
A genetic variant in LILRB5 (leukocyte immunoglobulin-like receptor subfamily-B) (rs12975366: T > C: Asp247Gly) has been reported to be associated with lower creatine phosphokinase (CK) and lactate dehydrogenase (LDH) levels. Both biomarkers are released from injured muscle tissue, making this variant a potential candidate for susceptibility to muscle-related symptoms. LILRB5/CD85c Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weig... | |||
TMPY-02030 |
CD82 Protein, Human, Recombinant (His)
CD82 molecule,SAR2,R2,KAI-1,4F9,KAI1,C33,T... |
Human | HEK293 Cells |
CD82, also known as KAI-1, structurally belongs to tetraspanin family while categorised as metastasis suppressor gene on functional grounds. KAI1/CD82 is localized on cell membrane and form interactions with other tetraspanins, integrins and chemokines which are respectively responsible for cell migration, adhesion and signalling. Downregulation of CD82 expression is associated with the advanced stages of many human cancers and correlates with the acquisition of metastatic potential. Recent stud... | |||
TMPY-01682 |
LILRB3/CD85a Protein, Human, Recombinant (His)
LIR3,PIRB,CD85A,HL9,MGC138403,LIR... |
Human | HEK293 Cells |
LILRB3/CD85a Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 47.6 kDa and the accession number is AAI04994.1. | |||
TMPY-00414 |
LILRA5/CD85f/ILT11 Protein, Human, Recombinant (His)
ILT-11,CD85F,LIR-9,LIR9,LILRB7,CD... |
Human | HEK293 Cells |
LILRA5/CD85f/ILT11 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 26.7 kDa and the accession number is A6NI73-1. | |||
TMPY-04781 |
LILRB1/CD85j/ILT2 Protein, Human, Recombinant (hFc)
ILT-2,LIR-1,CD85j,LIR1,MIR7,leukocyte immu... |
Human | HEK293 Cells |
LILRB1/CD85j/ILT2 Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 73.9 kDa and the accession number is D9IDM8. | |||
TMPY-01180 |
CD86 Protein, Human, Recombinant (His)
CD86 antigen,B70,B7.2,B7-2,CD2 |
Human | HEK293 Cells |
CD86 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 26.6 kDa and the accession number is P42081-3. | |||
TMPK-00355 |
LILRB3/CD85a Protein, Human, Recombinant (His & Avi), Biotinylated
ILT5,HL9,LIR3CD85A,ILT-5,PIRB,LILRB3,LIR3,... |
Human | HEK293 Cells |
Leukocyte immunoglobulin-like receptor subfamily B (LILRB3), also known as ILT5, LIR3, and CD85a, is an immunoglobulin superfamily member that is involved in immune regulation. Subfamily B members have cytoplasmic immunoreceptor tyrosine-based inhibitory motifs (ITIMs) that inhibit signaling events via phosphatase SHP-1.LILRB3 may act as receptor for class I MHC antigens. Becomes activated upon coligation of LILRB3 and immune receptors, such as FCGR2B and the B-cell receptor. LILRB3/CD85a Protei... | |||
TMPK-00914 |
LILRA4/CD85g Protein, Human, Recombinant (His & Avi)
LILRA4,ILT-7,ILT7MGC129598,ILT7,MGC129597,CD |
Human | HEK293 Cells |
LILRA4/CD85g Protein, Human, Recombinant (His & Avi) is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 49.5 kDa and the accession number is P59901. | |||
TMPJ-00157 |
CD82 Protein, Human, Recombinant (hFc)
Tetraspanin-27,KAI1,ST6,TSPAN27,TSPAN274F9,CD8<... |
Human | HEK293 Cells |
CD82 antigen, also known as Kai-1, is a widely expressed palmitoylated molecule of the tetraspanin superfamily. KAI1/CD82 is localized on cell membrane and form interactions with other tetraspanins, integrins and chemokines which are respectively responsible for cell migration, adhesion and signaling. CD82/Kai-1 is a component of the promiscuous TIMP-1 interacting protein complex on the cell surface of human adenocarcinoma cells and gives insight into tumorigenic metastatic potential. CD82/Kai-1... | |||
TMPK-01101 |
LILRB2/CD85d/ILT4 Domain1 & 2 Protein, Human, Recombinant (His)
LILRB2,ILT-4,CD85d,MIR10,LIR2,ILT4,ILT4 |
Human | HEK293 Cells |
The immunoglobulin-like transcript (ILT) comprise a family of activating and inhibitory type immunoreceptors whose genes are located in the same locus that encodes killer cell Ig-like receptors (KIR). ILT4, also known as LIR-2 and LILRB2, is a type I transmembrane protein expressed primarily on monocytes and dendritic cells (DC). LILRB2 is a receptor for class I MHC antigens. Recognizes a broad spectrum of HLA-A, HLA-B, HLA-C, HLA-G and HLA-F alleles. LILRB2/CD85d/ILT4 Domain1 & 2 Protein, Human... | |||
TMPY-04258 |
CD84 Protein, Cynomolgus, Recombinant (hFc)
CD84 molecule |
Cynomolgus | HEK293 Cells |
CD84 Protein, Cynomolgus, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 49.2 kDa and the accession number is F6QA53. | |||
TMPJ-01070 |
CD83 Protein, Human, Recombinant (hFc)
hCD83,B-cell activation protein,CD |
Human | HEK293 Cells |
CD83 antigen is a single-pass type I membrane protein which contains one Ig-like V-type (immunoglobulin-like) domain. CD83 is expressed by activated lymphocytes, Langerhans cells and interdigitating reticulum cells. It contains one Ig-like V-type (immunoglobulin-like) domain. , the soluble CD83 has the opposite effect and has an immune inhibitory capacity. Due to its immune inhibitory function, CD83 may play a significant role in antigen presentation or the cellular interactions that follow lymp... | |||
TMPK-01098 |
LILRB2/CD85d/ILT4 Protein, Human, Recombinant (His & Avi)
MIR10,CD85d,ILT-4,ILT4,ILT4CD... |
Human | HEK293 Cells |
The immunoglobulin-like transcript (ILT) comprise a family of activating and inhibitory type immunoreceptors whose genes are located in the same locus that encodes killer cell Ig-like receptors (KIR). ILT4, also known as LIR-2 and LILRB2, is a type I transmembrane protein expressed primarily on monocytes and dendritic cells (DC). LILRB2 is a receptor for class I MHC antigens. Recognizes a broad spectrum of HLA-A, HLA-B, HLA-C, HLA-G and HLA-F alleles. LILRB2/CD85d/ILT4 Protein, Human, Recombinan... | |||
TMPK-00682 |
LILRB1/CD85j/ILT2 Protein, Rhesus macaque, Recombinant (aa 1-474, hFc)
LIR1,CD85J,ILT-2,MIR7,XXbac-BCX85... |
Rhesus | HEK293 Cells |
LILRB1/CD85j/ILT2 Protein, Rhesus macaque, Recombinant (aa 1-474, hFc) is expressed in HEK293 mammalian cells with C-hFc tag. The predicted molecular weight is 75.2 kDa and the accession number is NP_001035762.2. | |||
TMPY-06880 |
CD86 Protein, Human, Recombinant (His & Avi), Biotinylated
B7-2,CD28LG2,B70,B7.2,LAB72,CD |
Human | HEK293 Cells |
CD86 Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with His and Avi tag. The predicted molecular weight is 28.42 kDa and the accession number is NP_008820.4. | |||
TMPY-06257 |
CD8A & CD8B Heterodimer Protein, Cynomolgus, Recombinant (Flag & His)
|
Cynomolgus | HEK293 Cells |
CD8A & CD8B Heterodimer Protein, Cynomolgus, Recombinant (Flag & His) is expressed in HEK293 mammalian cells with Flag and His tag. The predicted molecular weight is 44.27 kDa and the accession number is XP_001092778.2&XP_005575417.1. | |||
TMPK-00344 |
LILRB5/CD85c Protein, Human, Recombinant (His & Avi)
CD85C,LIR8,LIR-8 |
Human | HEK293 Cells |
LILRB5, also known as CD85c andLIR-8, belongs to a family of transmembrane glycoproteins that negatively regulate immune cell activation. Mature human LIR-8 consists of a 435 amino acid (aa) extracellular domain with four Ig-like domains, a 21 aa transmembrane segment, and a 111 aa cytoplasmic domain with two immunoreceptor tyrosine-based inhibitory motifs (ITIM). LILRB5 may act as receptor for class I MHC antigens. LILRB5/CD85c Protein, Human, Recombinant (His & Avi) is expressed in HEK293 mamm... | |||
TMPY-05186 |
LILRB5/CD85c Protein, Human, Recombinant (His), Biotinylated
LIR-8,LIR8,leukocyte immunoglobulin like r... |
Human | HEK293 Cells |
A genetic variant in LILRB5 (leukocyte immunoglobulin-like receptor subfamily-B) (rs12975366: T > C: Asp247Gly) has been reported to be associated with lower creatine phosphokinase (CK) and lactate dehydrogenase (LDH) levels. Both biomarkers are released from injured muscle tissue, making this variant a potential candidate for susceptibility to muscle-related symptoms. LILRB5/CD85c Protein, Human, Recombinant (His), Biotinylated is expressed in HEK293 mammalian cells with His tag. The predicted ... | |||
TMPK-00234 |
CD84 Protein, Human, Recombinant (His & Avi)
CD84,DKFZp781E2378,Hly9-... |
Human | HEK293 Cells |
Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of CD5 B lymphocytes in peripheral blood, lymphoid organs and bone marrow. The main feature of the disease is accumulation of the malignant cells due to decreased apoptosis. CD84 belongs to the signaling lymphocyte activating molecule family of immunoreceptors, and has an unknown function in CLL cells. | |||
TMPY-05015 |
CD81 Protein, Mouse, Recombinant (His)
Tapa-1,CD81 molecule,Tspan28,Tapa... |
Mouse | HEK293 Cells |
CD81 Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 11.8 kDa and the accession number is P35762. | |||
TMPK-00601 |
LILRB4/CD85k/ILT3 Protein, Human, Recombinant (His & Avi)
ILT3,ILT-3,HM18,LILRB4,CD85K,LIR5 |
Human | HEK293 Cells |
LILRB4,also known as CD85k and LIR-5, ILT-3, is an approximately 60 kDa transmembrane glycoprotein that negatively regulates immune cell activation. Mature human ILT-3 consists of a 238 amino acid (aa) extracellular domain with two Ig-like domains, a 21 aa transmembrane segment, and a 168 aa cytoplasmic domain with 3 immunoreceptor tyrosine-based inhibitory motifs (ITIM).LILRB4 is receptor for class I MHC antigens. Recognizes a broad spectrum of HLA-A, HLA-B, HLA-C and HLA-G alleles. LILRB4/CD8... | |||
TMPY-04709 |
CD81 Protein, Cynomolgus, Rhesus, Recombinant (His)
CD81 molecule |
Cynomolgus,Rhesus | HEK293 Cells |
CD81 Protein, Cynomolgus, Rhesus, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 11.7 kDa and the accession number is XP_005576958.1. | |||
TMPY-00045 |
CD81 Protein, Human, Recombinant (His)
TSPAN28,TAPA1,CVID6,S5.7,CD81 mol... |
Human | HEK293 Cells |
CD81 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 12.1 kDa and the accession number is A0A024RCB7. | |||
------------------------ 更多 ------------------------ |